Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Roumiguie

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2023
Estimation of Donor Renal Function After Living Donor Nephrectomy: The Value of the Toulouse-Rangueil Predictive ModelThomas Prudhomme, Mathieu Roumiguie, Marc Olivier Timsit
Radiology|April 15, 2020
Closing the Gap between Prostate Cancer and Deep Learning Detection ToolsOlivier Meyrignac, Richard Aziza, Mathieu Roumiguie, et al.
European Urology|April 11, 2021
Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907-15: Linking FGFR3 Mutation Status and Luminal Papillary Subtype to Response to Cisplatin-based Chemotherapy in Bladder CancerMathieu Roumiguie, Alberto Contreras-Sanz, Peter C Black
Nature Communications|August 11, 2021
Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapyMathieu Roumiguie, Alberto Contreras-Sanz, Gunjan Kumar, et al.
Urology Case Reports|June 19, 2019
Migration of an abdominal mesh into a reconstructed ileal neobladder, diagnosis and management: A case reportJoseph Zgheib, Mathieu Roumiguie, Michel Soulie, et al.
Cancers|June 28, 2023
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic PracticesEmmanuel Deshayes, Cyril Fersing, Constance Thibault, et al.
The French Journal of Urology|June 27, 2024
Sexual and couple outcomes of vasectomy: Results of a French questionnaire surveyWafik Touil, Boris Delaunay, Thomas Prudhomme, et al.
Microsurgery|September 12, 2019
The super thin external pudendal artery (STEPA) free flap for oropharyngeal reconstruction - A case reportAgnès Dupret-Bories, Mathieu Roumiguie, Guillaume De Bonnecaze, et al.
World Journal of Urology|September 9, 2025
Management of renal cancer with inferior vena cava extension over 30 years: a bi-centric studyThomas Poirier, Benoit Mesnard, Mathieu Roumiguie, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 9, 2016
Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivityQuentin Ballouhey, Jalesh N Panicker, Catherine Mazerolles, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2023
Estimation of Donor Renal Function After Living Donor Nephrectomy: The Value of the Toulouse-Rangueil Predictive ModelThomas Prudhomme, Mathieu Roumiguie, Marc Olivier Timsit
Radiology|April 15, 2020
Closing the Gap between Prostate Cancer and Deep Learning Detection ToolsOlivier Meyrignac, Richard Aziza, Mathieu Roumiguie, et al.
European Urology|April 11, 2021
Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907-15: Linking FGFR3 Mutation Status and Luminal Papillary Subtype to Response to Cisplatin-based Chemotherapy in Bladder CancerMathieu Roumiguie, Alberto Contreras-Sanz, Peter C Black
Nature Communications|August 11, 2021
Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapyMathieu Roumiguie, Alberto Contreras-Sanz, Gunjan Kumar, et al.
Urology Case Reports|June 19, 2019
Migration of an abdominal mesh into a reconstructed ileal neobladder, diagnosis and management: A case reportJoseph Zgheib, Mathieu Roumiguie, Michel Soulie, et al.
Cancers|June 28, 2023
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic PracticesEmmanuel Deshayes, Cyril Fersing, Constance Thibault, et al.
The French Journal of Urology|June 27, 2024
Sexual and couple outcomes of vasectomy: Results of a French questionnaire surveyWafik Touil, Boris Delaunay, Thomas Prudhomme, et al.
Microsurgery|September 12, 2019
The super thin external pudendal artery (STEPA) free flap for oropharyngeal reconstruction - A case reportAgnès Dupret-Bories, Mathieu Roumiguie, Guillaume De Bonnecaze, et al.
World Journal of Urology|September 9, 2025
Management of renal cancer with inferior vena cava extension over 30 years: a bi-centric studyThomas Poirier, Benoit Mesnard, Mathieu Roumiguie, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 9, 2016
Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivityQuentin Ballouhey, Jalesh N Panicker, Catherine Mazerolles, et al.
Pageof 4